Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. diagnostic tool development
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Books
Events
Downloads
Videos

Refine by
Date

  • This Year
  • Older

Diagnostic Tool Development Articles & Analysis

143 news found

CD Bioparticles Launches Advanced Bio-Targeted Small Molecules Conjugated Magnetic Nanoparticles for Targeted Cancer Therapy

CD Bioparticles Launches Advanced Bio-Targeted Small Molecules Conjugated Magnetic Nanoparticles for Targeted Cancer Therapy

With years of experience in the pharmaceutical and life science sectors, CD Bioparticles has announced the expansion of its custom services to include the synthesis of Bio-Targeted Small Molecules Conjugated Magnetic Nanoparticles (MNPs). These customized magnetic particles can be conjugated with the biologically targeted small molecules desired by researchers, and have a uniform size and shape, ...

ByCD Bioparticles


Creative Diagnostics Launches Human Hybrid IgM Control Monoclonal Antibodies to Accelerate Diagnostic Assay Development

Creative Diagnostics Launches Human Hybrid IgM Control Monoclonal Antibodies to Accelerate Diagnostic Assay Development

These sera are valuable for many aspects of diagnostics, especially for developing and validating diagnostic tests. ...

ByCreative Diagnostics


CD Bioparticles Launches Purified Exosomes for Drug Delivery and Therapeutic Research

CD Bioparticles Launches Purified Exosomes for Drug Delivery and Therapeutic Research

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the availability of its quality Purified Exosomes to support research in drug delivery, regenerative medicine, and various therapeutic applications. Exosomes are extracellular vesicles secreted by human cells that exhibit biofilm characteristics. They have a particle size of 30-150 ...

ByCD Bioparticles


Creative Diagnostics Announces Antiviral Drug Discovery Services to Accelerate Therapeutic Development

Creative Diagnostics Announces Antiviral Drug Discovery Services to Accelerate Therapeutic Development

As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics has announced the expansion and enhancement of its comprehensive Drug Discovery Services to help scientists advance antiviral therapeutic development, including target selection and validation, hit selection and optimization, and preclinical ...

ByCreative Diagnostics


Creative Diagnostics Expands Hepatitis B Research Tools with High Performance HBV Surface Antigen L-Proteins

Creative Diagnostics Expands Hepatitis B Research Tools with High Performance HBV Surface Antigen L-Proteins

These rigorously validated antigens are suitable for use in HBV mimetics, standard antigens for ELISA, and Western blotting, and are designed to assist researchers in advancing their understanding of HBV infection and developing novel diagnostic methods or more effective antiviral therapies. ...

ByCreative Diagnostics


Ace Therapeutics Accelerates Preclinical Depression Investigation by Providing Depression-Related Behavior Tests

Ace Therapeutics Accelerates Preclinical Depression Investigation by Providing Depression-Related Behavior Tests

With the advancement of biotechnology and biological tools, such as diagnostic technology and animal model development, researchers can further investigate the mechanisms related to depression and thereby develop effective therapies targeting depression. Ace Therapeutics Psychiatry Team is committed to supporting scientists in ...

ByAce Therapeutics


Diving Deeper in Rare Disease Research: Protheragen Unveils Diagnostic Development Services

Diving Deeper in Rare Disease Research: Protheragen Unveils Diagnostic Development Services

Protheragen, a dedicated preclinical research service provider specializing in rare diseases, announces its comprehensive diagnostic development services aimed at empowering researchers in the realm of rare disease research and drug development. ...

ByProtheragen


Protheragen Announces Vaccine Development Services Targeting Rare Infectious Diseases

Protheragen Announces Vaccine Development Services Targeting Rare Infectious Diseases

Protheragen is proud to release the launch of its comprehensive vaccine development solutions tailored to advance research and development in the field of infectious diseases. ...

ByProtheragen


Ace Therapeutics Releases Cardiovascular Disease Model Development Services to Power Up Related Preclinical Research

Ace Therapeutics Releases Cardiovascular Disease Model Development Services to Power Up Related Preclinical Research

Ace Therapeutics is proud to announce the launch of its cardiovascular disease model development services, aiming to empower researchers and pharmaceutical companies with advanced tools and models to accelerate the study of cardiovascular diseases and drug discovery. ...

ByAce Therapeutics


Creative Diagnostics Launches Comprehensive ELISA Based Assays for Vaccine Development

Creative Diagnostics Launches Comprehensive ELISA Based Assays for Vaccine Development

As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics is proud to announce the launch of its comprehensive portfolio of ELISA Based Assays for vaccine development and bioprocess applications. Vaccine development involves a variety of assays to support vaccine research and development, from early preclinical studies to final production, quality ...

ByCreative Diagnostics


Alfa Chemistry Provides Customized Synthesis Services for Biotinylation Reagents   

Alfa Chemistry Provides Customized Synthesis Services for Biotinylation Reagents  

Alfa Chemistry's custom synthesis of biotin reagents for antibody pretargeting facilitates the development of highly specific and efficient diagnostic and therapeutic strategies. ...

ByAlfa Chemistry


Creative Diagnostics Launches New P53 and Tp53 Antibodies for Cancer Research

Creative Diagnostics Launches New P53 and Tp53 Antibodies for Cancer Research

This comprehensive collection of research tools will empower scientists to advance their understanding of P53 and TP53 and their role in cancer development and progression. ...

ByCreative Diagnostics


Creative BioMart Unveils Comprehensive Lectin Portfolio for Diverse Research Applications

Creative BioMart Unveils Comprehensive Lectin Portfolio for Diverse Research Applications

Moreover, lectins have garnered attention in the commercial sphere, paving the way for the development of diagnostic tools, therapeutic agents, and food additives. ...

ByCreative BioMart


Biopharma PEG Assists ADC Development with Monodispersed PEGs

Biopharma PEG Assists ADC Development with Monodispersed PEGs

Biopharma PEG, a leading name in the pharmaceutical industry, is proud to announce a groundbreaking advancement in the field of Antibody-Drug Conjugate (ADC) development. The company now offers monodispersed Polyethylene Glycols (PEGs) on a scale ranging from grams to kilograms, and even on a ton scale. Notable PEGs include mPEG36-NH2, NH2-PEG24-COOH, OH-PEG9-OH, mPEG8-SPA, and more.ADCs ...

ByBiopharma PEG Scientific Inc


Daptomycin ReadyMade™ Solution to Power Up Spectrum and Microbiology Applications

Daptomycin ReadyMade™ Solution to Power Up Spectrum and Microbiology Applications

Amerigo Scientific, a distributor focused on providing critical products and services to biomedical and life science communities, unveils the addition of the reliable Daptomycin ReadyMade™ Solution to its growing portfolio of innovative products to power up spectrum and microbiology applications. Daptomycin is an essential antibiotic used in the treatment of serious bacterial infections, ...

ByAmerigo Scientific


Creative Diagnostics Introduces ELISA Kit Development Services to Support IVD Research

Creative Diagnostics Introduces ELISA Kit Development Services to Support IVD Research

Creative Diagnostics, a global leader in providing raw materials, antibodies, and reagents for the biotechnology industry, recently introduced comprehensive contract ELISA kit development services to the R&D and IVD communities, facilitating regulatory approval submissions. With expertise in antibody generation and immunoassay development, Creative Diagnostics can generate various diagnostic ...

ByCreative Diagnostics


Lifespin Announces Expansion of Laboratory Testing Capability

Lifespin Announces Expansion of Laboratory Testing Capability

“Our business model is driven by an understanding that scalable infrastructures, like those we have and are developing, are an indispensable prerequisite to foster clinical accessibility, affordability, and market penetration of precision medicine tools,” said Dr. ...

ByLifespin GmbH


ImmunogenX and Mayo Clinic Celiac Disease Study Published in Gastroenterology

ImmunogenX and Mayo Clinic Celiac Disease Study Published in Gastroenterology

About ImmunogenX ImmunogenX, Inc. is a clinical-stage biopharmaceutical company founded in 2013 and is supported by a team of world-renowned clinicians, scientists and advisors in celiac disease research. The company is developing latiglutenase (IMGX003) for celiac disease therapy. ImmunogenX is also developing a diagnostic tool ...

ByEntero Therapeutics, Inc.


Kidney and Pancreas Function Diagnostic Enzymes Are Now Available at Creative Enzymes

Kidney and Pancreas Function Diagnostic Enzymes Are Now Available at Creative Enzymes

Creative Enzymes, a global leader in diagnostic enzyme manufacturing and supply, is dedicated to offering a wide range of enzyme products as well as customized enzyme-related services for medical and research diagnosis. Recently, Creative Enzymes launched kidney and pancreas function diagnostic enzymes for the global market. The primary function of the kidney is to eliminate waste and excess ...

ByCreative Enzymes


Unbiased gene fusion analysis required in future cancer diagnostics

Unbiased gene fusion analysis required in future cancer diagnostics

Today about 20 cancer treatments approved by FDA and EMA are directed towards specific gene fusions, and the number of drugs available is growing annually. The increased importance of gene fusions in oncology is driving demand from diagnostic laboratories for scalable analytical solutions. RNA can be used to analyze gene fusions. Moreover, while DNA is largely identical in all cells, RNA ...

ByQlucore AB

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT